Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Hoffman M, Chansky PB, Bashyam AR, Boettler MA, Challa N, Dominguez A, Estupinan B, Gupta R, Hennessy K, Huckell SN, Hylwa-Deufel S, Karikari NA, Keller JJ, Kroshinsky D, Kullberg SA, Lake E, Lee KJ, Martinez E, Michels K, Mostaghimi A, Murphy W, Nutan F, Osler M, Pahalyants V, Patel T, Seminario-Vidal L, Strowd LC, Trinidad J, Vaudreuil A, Voller LM, Micheletti RG. Hoffman M, et al. Among authors: pahalyants v. JAMA Dermatol. 2021 Jun 1;157(6):712-715. doi: 10.1001/jamadermatol.2021.1136. JAMA Dermatol. 2021. PMID: 33950191 Free PMC article.
Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Klebanov N, Pahalyants V, Murphy WS, Theodosakis N, Zubiri L, Klevens RM, Kwatra SG, Lilly E, Reynolds KL, Semenov YR. Klebanov N, et al. Among authors: pahalyants v. Oncologist. 2021 May;26(5):e898-e901. doi: 10.1002/onco.13768. Epub 2021 Apr 17. Oncologist. 2021. PMID: 33783099 Free PMC article.
Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.
Wongvibulsin S, Pahalyants V, Kalinich M, Murphy W, Yu KH, Wang F, Chen ST, Reynolds K, Kwatra SG, Semenov YR. Wongvibulsin S, et al. Among authors: pahalyants v. J Am Acad Dermatol. 2022 Mar;86(3):563-572. doi: 10.1016/j.jaad.2021.03.094. Epub 2021 Apr 2. J Am Acad Dermatol. 2022. PMID: 33819538 Free PMC article.
Characterization of the active Medicare dermatology workforce.
Murphy W, Pahalyants V, Gunasekera N, Shi CR, Nambudiri VE. Murphy W, et al. Among authors: pahalyants v. J Am Acad Dermatol. 2022 May;86(5):1140-1142. doi: 10.1016/j.jaad.2021.03.123. Epub 2021 Apr 18. J Am Acad Dermatol. 2022. PMID: 33878408 No abstract available.
Latent class analysis identification of prurigo nodularis comorbidity phenotypes.
Wongvibulsin S, Parthasarathy V, Pahalyants V, Murphy W, Sutaria N, Roh YS, Bordeaux ZA, Deng J, Taylor MT, Semenov YR, Kwatra SG. Wongvibulsin S, et al. Among authors: pahalyants v. Br J Dermatol. 2022 May;186(5):903-905. doi: 10.1111/bjd.20957. Epub 2022 Mar 25. Br J Dermatol. 2022. PMID: 34927720 No abstract available.
Telemedicine and dermatology hospital consultations during the COVID-19 pandemic: a multi-centre observational study on resource utilization and conversion to in-person consultations during the COVID-19 pandemic.
Trinidad J, Gabel CK, Han JJ, Bonomo L, Cartron A, Chand S, Coburn W, Daveluy S, Davis M, DeNiro KL, Guggina LM, Hennessy K, Hoffman M, Katz K, Keller JJ, Kim SJ, Konda S, Lake E, Lincoln FN, Lo JA, Markova A, Marvin EK, Micheletti RG, Newman S, Nutan FNU, Nguyen CV, Pahalyants V, Patel J, Rahnama-Moghadam S, Rambhatla PV, Riegert M, Reingold RE, Robinson DB, Rrapi R, Sartori-Valinotti JC, Seminario-Vidal L, Sharif-Sidi Z, Smogorzewski J, Spaccarelli N, Stewart JR, Tuttle SD, Ulrich MN, Wanat KA, Di Xia F, Kaffenberger B, Kroshinsky D. Trinidad J, et al. Among authors: pahalyants v. J Eur Acad Dermatol Venereol. 2022 May;36(5):e323-e325. doi: 10.1111/jdv.17898. Epub 2022 Jan 20. J Eur Acad Dermatol Venereol. 2022. PMID: 34932237 No abstract available.
29 results